Bionano Genomics, Inc. (BNGO)

Bionano Genomics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	39	73	434	865	472	33
Market Cap Growth	-82.14%	-83.07%	-49.86%	83.26%	1336.38%	-37.52%
Enterprise Value	24	51	332	625	450	36
PE Ratio	-	-0.32	-3.27	-11.94	-11.48	-1.10
PS Ratio	1.05	2.03	15.59	48.09	55.49	3.24
PB Ratio	0.48	0.76	1.74	2.57	13.45	9.09
P/FCF Ratio	-0.50	-0.58	-3.39	-11.69	-12.31	-1.11
P/OCF Ratio	-0.50	-0.59	-3.47	-12.02	-12.31	-1.11
EV/Sales Ratio	0.64	1.40	11.93	34.74	52.89	3.52
EV/EBITDA Ratio	-0.22	-0.24	-2.76	-8.54	-12.13	-1.35
EV/EBIT Ratio	-0.20	-0.22	-2.54	-8.09	-11.66	-1.29
EV/FCF Ratio	-0.37	-0.40	-2.59	-8.44	-11.74	-1.20
Debt / Equity Ratio	0.46	0.83	0.05	0.03	0.47	5.56
Debt / EBITDA Ratio	-0.18	-0.37	-0.10	-0.15	-0.44	-0.76
Debt / FCF Ratio	-0.31	-0.63	-0.09	-0.14	-0.43	-0.68
Quick Ratio	1.05	1.12	3.36	11.70	4.61	0.90
Current Ratio	1.46	1.40	4.38	12.47	5.23	1.07
Asset Turnover	0.18	0.15	0.09	0.05	0.23	0.39
Interest Coverage	-42.91	-44.41	-437.63	-83.31	-15.31	-12.03
Return on Equity (ROE)	-176.90%	-140.60%	-47.10%	-20.90%	-320.00%	-15680.10%
Return on Assets (ROA)	-109.90%	-96.90%	-40.80%	-19.60%	-111.00%	-114.50%
Return on Capital (ROIC)	-169.99%	-120.63%	-50.53%	-22.18%	-75.01%	-109.18%
Earnings Yield	-575.54%	-316.71%	-30.59%	-8.38%	-8.71%	-90.77%
FCF Yield	-310.26%	-172.83%	-29.52%	-8.56%	-8.12%	-90.09%
Buyback Yield / Dilution	-74.60%	-18.08%	-4.49%	-165.50%	-596.03%	-111.64%
Total Shareholder Return	-74.60%	-18.08%	-4.49%	-165.50%	-596.03%	-111.64%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).